These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30618857)

  • 1. Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures.
    Durant CF; Paterson LM; Turton S; Wilson SJ; Myers JFM; Muthukumaraswamy S; Venkataraman A; Mick I; Paterson S; Jones T; Nahar LK; Cordero RE; Nutt DJ; Lingford-Hughes A
    Front Psychiatry; 2018; 9():664. PubMed ID: 30618857
    [No Abstract]   [Full Text] [Related]  

  • 2. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
    Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
    Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment-a pharmacokinetic-pharmacodynamic study.
    Paterson LM; Barker D; Cro S; Mozgunov P; Phillips R; Smith C; Nahar L; Paterson S; Lingford-Hughes AR
    Trials; 2022 Oct; 23(1):880. PubMed ID: 36258248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: lessons learned from a human laboratory investigation.
    Farokhnia M; Deschaine SL; Sadighi A; Farinelli LA; Lee MR; Akhlaghi F; Leggio L
    Mol Psychiatry; 2021 Feb; 26(2):545-555. PubMed ID: 30382188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
    Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
    Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics.
    Ozsoy S; Esel E; Turan T; Kula M
    Alcohol; 2007 Dec; 41(8):551-6. PubMed ID: 18047908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and acylated ghrelin plasma levels as potential long-term response markers in alcohol-dependent patients receiving high-dose of the GABA-B receptor agonist baclofen.
    Geisel O; Hellweg R; Wernecke KD; Wiedemann K; Müller CA
    Psychiatry Res; 2019 Feb; 272():431-437. PubMed ID: 30611960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderation of baclofen response by a GABA
    Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
    Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose baclofen on cue reactivity in alcohol dependence: A randomized, placebo-controlled pharmaco-fMRI study.
    Beck A; Pelz P; Lorenz RC; Charlet K; Geisel O; Heinz A; Wüstenberg T; Müller CA
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1206-1216. PubMed ID: 30217552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
    Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
    Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.
    Reynaud M; Aubin HJ; Trinquet F; Zakine B; Dano C; Dematteis M; Trojak B; Paille F; Detilleux M
    Alcohol Alcohol; 2017 Jul; 52(4):439-446. PubMed ID: 28525555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic characteristics of aranidipine sustained-release, enteric-coated tablets in healthy Chinese men: a phase I, randomized, open-label, single- and multiple-dose study.
    Jiang J; Tian L; Huang Y; Li Y; Xu L
    Clin Ther; 2008 Jul; 30(7):1290-9. PubMed ID: 18691988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
    Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
    J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticraving Effect of Baclofen in Alcohol-Dependent Patients.
    Imbert B; Alvarez JC; Simon N
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1602-8. PubMed ID: 26207768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.